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Abstract
Background: Mental health and substance use disorders are the leading causes of global disability in children and youth. Both
tend to first onset or escalate in adolescence and young adulthood, calling for effective prevention during this time. The Climate
Schools Combined (CSC) study was the first trial of a Web-based combined universal approach, delivered through school classes,
to prevent both mental health and substance use problems in adolescence. There is also limited evidence for the cost-effectiveness
of school-based prevention programs.
Objective: The aim of this protocol paper is to describe the CSC follow-up study, which aims to determine the long-term efficacy
and cost-effectiveness of the CSC prevention program for depression, anxiety, and substance use (alcohol and cannabis use) up
to 7 years post intervention.
Methods: A cluster randomized controlled trial (the CSC study) was conducted with 6411 participants aged approximately 13.5
years at baseline from 2014 to 2016. Participating schools were randomized to 1 of 4 conditions: (1) control (health education as
usual), (2) Climate Substance Use (universal substance use prevention), (3) Climate Mental Health (universal mental health
prevention), or (4) CSC (universal substance use and mental health prevention). It was hypothesized that the CSC program would
be more effective than conditions (1) to (3) in reducing alcohol and cannabis use (and related harms), anxiety, and depression
symptoms as well as increasing knowledge related to alcohol, cannabis, anxiety, and depression. This long-term study will invite
follow-up participants to complete 3 additional Web-based assessments at approximately 5, 6, and 7 years post baseline using
multiple sources of locator information already provided to the research team. The primary outcomes include alcohol and cannabis
use (and related harms) and mental health symptoms. An economic evaluation of the program will also be conducted using both
data linkage as well as self-report resource use and quality of life measures. Secondary outcomes include self-efficacy, social
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networks, peer substance use, emotion regulation, and perfectionism. Analyses will be conducted using multilevel mixed-effects
models within an intention-to-treat framework.
Results: The CSC long-term follow-up study is funded from 2018 to 2022 by the Australian National Health and Medical
Research Council (APP1143555). The first follow-up wave commences in August 2018, and the results are expected to be
submitted for publication in 2022.
Conclusions: This is the first study to provide a long-term evaluation of combined universal substance use and mental health
prevention up to 7 years post intervention. Evidence of sustained benefits into early adulthood would provide a scalable,
easy-to-implement prevention strategy with the potential for widespread dissemination to reduce the considerable harms, burden
of disease, injury, and social costs associated with youth substance use and mental disorders.
International Registered Report Identifier (IRRID): PRR1-10.2196/11372
(JMIR Res Protoc 2018;7(11):e11372)   doi:10.2196/11372
KEYWORDS
alcohol abuse; prevention; depression; anxiety; costs and cost analysis; school; eHealth
Introduction
Background
Mental health and substance use disorders are the leading causes
of global disability, accounting for 25% of total disability in
children and youth [1]. Every year, mental and substance use
disorders conservatively cost the Australian community over
Aus $12.7 billion [2]. The burden of substance use and mental
disorders now account for 1 in every 10 lost years of health
globally [3]. The most common mental disorders are anxiety
and depression [4,5], with the most commonly used substances
in Western countries, such as Australia, being alcohol and
cannabis. To reduce the cost and burden of depression, anxiety,
and substance use, timely and effective prevention is critical.
Epidemiological studies show that between 40% [6] and 50%
[7] of the population in Western countries will suffer from a
depressive, anxiety, or substance use disorder during their
lifetime. Furthermore, depression, anxiety, and substance use
disorders typically emerge before the age of 25 years [8]. From
the ages of 13 to 24 years, there is an increased susceptibility
for the development of depression, anxiety, and substance use
disorders. Longitudinal life course studies show that transitions
from childhood to adolescence and from adolescence to young
adulthood are marked by significant increases in anxiety
disorders, depression, and substance use disorders [9]. In
addition, even small elevations in mental health symptoms in
adolescence increase the likelihood of developing a full-blown
mental disorder later in life [10]. Substance use during
adolescence is also a significant global problem, resulting in a
number of adverse outcomes including violence, accidental
injury, self-harm, suicide, and an increased risk of developing
mental illness [11]. Although the majority of adolescents will
not meet criteria for a full-blown substance use disorder [12],
a substantial portion will use alcohol at harmful levels [13].
Data from nationally representative surveys consistently show
rates of substance use (namely alcohol use) increase steeply
between the ages of 13 and 18 years [14-16]. In the general
population, approximately 25% of people with a substance use,
anxiety, or mood disorder will experience comorbidity with
another class of these disorders in any 12-month period [17].
Of particular concern, individuals with comorbid disorders are
harder to treat, suffer a more chronic illness course, and
experience poorer outcomes later in life than those with no
disorder or single disorders [18,19].
To halt the escalation and associated burden of disease,
prevention efforts need to be commenced before the onset and
acceleration of substance use, depressive, and anxiety symptoms
into well-established patterns and disorders. Adolescence is a
key time to do this. School-based programs have been shown
to reduce both substance use and depression and anxiety
symptoms [20-22]. However, to date, prevention programs tend
to target single disorders in isolation, ignoring the comorbidity
and common risk factor shared by substance use and mental
disorders [23,24]. Until recently, there were no prevention
models targeting depression, anxiety, and substance use
simultaneously.
Few studies have examined the effectiveness of prevention
approaches for substance use, depression, and anxiety beyond
secondary school. There is limited evidence from studies in the
United States [25,26] that receiving the universal Life Skills
Training substance use prevention program in year 6-7 (ages
12-13 years) reduced risk of alcohol-related problems and illicit
drug use into early adulthood (ages 18-22 years). Further
investigations of the Life Skills Training program have indicated
that these reductions in substance use, in turn, demonstrated
significant secondary benefits on depression symptoms at the
age of 22 years [27]. According to recent reviews, the durability
of universal prevention programs for anxiety and depression
has not been investigated beyond 4 years post intervention and
into the young adult years [28-30]. The secondary effects of
prevention for anxiety and depression on substance use are
rarely investigated and have been identified as a high priority
future direction in prevention research [31]. Moreover,
assessment over the longer term for interventions instigated in
adolescence is important as adolescents are increasingly exposed
to drugs and alcohol, and personality vulnerabilities are triggered
by the unique challenges associated with early adulthood [32].
The Climate School Combined Study: First
Randomized Controlled Trial of Simultaneous
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Universal Prevention for Anxiety, Depression, and
Substance Misuse
The Climate School Combined (CSC) study commenced in
2014 as the first randomized controlled trial (RCT) of a
combined approach to preventing depression, anxiety, and
substance misuse (focusing on alcohol and cannabis) in
adolescence [33]. This study was a 4-armed, cluster RCT, in
which participating schools were randomly allocated to 1 of 4
conditions: (1) CSC intervention; (2) Climate Schools Substance
Use; (3) Climate Schools Mental Health, or (4) Control (health
and physical education as usual). Participants allocated to the
CSC intervention received 18 × 40-min classroom lessons
focused on depression, anxiety, alcohol, and cannabis. Each
lesson includes both computer-based and manualized classroom
activities. The computer-based component is delivered on the
Web to individual students who log on to view cartoon storylines
that impart information about anxiety and depressive symptoms,
alcohol, and cannabis. The classroom activities are delivered
by the teacher and aim to reinforce the learning outcomes
outlined in the cartoons and allow interactive communication
between students. These lessons adopt a harm minimization
approach in relation to substance use and utilize cognitive
behavioral skills and strategies to assist students in identifying
and reducing problematic mental health symptoms. Those
allocated to Climate Schools Substance Use intervention
received 12 × 40-min lessons focused on alcohol and cannabis
use, those allocated to the Climate Schools Mental Health
intervention received 6 × 40-min lessons focused on anxiety
and depression, whereas those in the control condition received
health education as usual. Further details about the intervention
components and groups have been previously reported [33].
The primary aim of the original CSC study was to assess the
effectiveness of delivering a comprehensive prevention strategy
(the CSC intervention) targeting depression, anxiety, and
substance use (alcohol and cannabis) in reducing the onset and
escalation of mental health symptoms, substance use and related
harms, and increasing knowledge in relation to these issues. A
total of 71 schools and 6411 students aged 13 to 14 years at
baseline participated in the trial. Although the initial phase of
the study did not specifically aim to test the cost-effectiveness
of the intervention, resource use questions used in
cost-effectiveness analysis were included in the study from
baseline (2014).
Sustaining Prevention Effects Into Young Adulthood:
The Need for Longer-Term Follow-Up
At ages 17 to 18 years, the CSC trial cohort is now nearing early
adulthood in 2018. This transition, from adolescence to early
adulthood, represents a unique developmental period
characterized by numerous personal and social role changes
including new social relationships and living arrangements,
increased financial and social independence, and pursuit of
employment and/or higher education. Along with increased
exposure to alcohol and cannabis during this period, mental
health symptoms often become more pronounced with the onset
of new challenges, increased autonomy, and formation of new
friendship circles. A review of longitudinal epidemiological
studies focusing on the transition from adolescence to young
adulthood found that rates of any mental or substance use
disorder more than doubled, as did the use of illicit drugs [9].
Specifically, substance use, anxiety, and depression begin to
increase in adolescence and continue to increase significantly
into early adulthood [34-36].
Despite evidence demonstrating that school-based prevention
efforts can interrupt the trajectory of growth in substance use
and mental health symptoms during adolescence [21,22,37],
very little research has focused on whether these effects can be
sustained into the critical period of young adulthood [38]. The
majority of existing prevention programs have a very limited
evidence base beyond 3 years [22,38,39]. It is therefore unclear
whether prevention effects are sustained into young adulthood,
when adult vocational and social roles are established, and rates
of substance use and mental health problems are highest. Even
small disruptions have potentially significant economic
consequences, with economic modeling suggesting that even
modest long-term reductions in substance use would lead to
substantial societal benefits [40]. Evaluation of long-term
outcomes and cost-effectiveness of school-based prevention
programs for substance use, anxiety, and depression is a critical
knowledge gap, and the long-term effectiveness of combining
mental health and substance use prevention is unknown.
The Climate Schools Combined Long-Term Follow-Up
Study
The CSC long-term follow-up study will be the first in the world
to examine the long-term effectiveness of a combined approach
to the universal prevention of anxiety, depression, and substance
use disorders delivered on the Web. It will extend the follow-up
of the existing CSC cohort by an additional 3 time points (5, 6,
and 7 years post initial baseline assessment in 2014). There is
limited evidence to suggest that when delivered in isolation,
mental health and substance use prevention programs have
secondary benefits on comorbid conditions [41,42]. This
suggests the possibility of powerful multiplicative effects of
mental health and substance use prevention when delivered in
combination. This study will provide evidence on the long-term
effectiveness of a combined approach to prevent mental health
(anxiety and depression) and substance use (alcohol and
cannabis) problems and evaluate the cost-effectiveness of such
an approach. This combined approach will be compared with
mental health and substance use prevention delivered in isolation
and to education as usual (a control group). Primary outcomes
include alcohol and cannabis use and related harms, and mental
health symptoms. An economic evaluation of the program will
utilize data linkage as well as self-reported resource use (use of
health care staff time, facilities, and consumables) and quality
of life measures. By investigating the long-term effects and
cost-effectiveness of a combined approach to preventing mental
health and substance use problems, this study will provide
crucial information about which prevention approaches are most
sustainable and whether and when additional booster sessions
might be needed. To further understand intervention effects
over the long term, it is important to explore potential
moderators and mediators of the intervention. Research has
shown that emotion regulation [43], self-efficacy [44],
personality domains (such as perfectionism) [45], social
networks [46], and broad internalizing and externalizing domains
[47] are important factors to consider in relation to substance
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use and mental health and will be considered as potential
moderators and/or mediators in this study.
Cost-Effectiveness of Universal School-Based
Prevention
There is limited evidence demonstrating the value for money
of school-based programs to prevent depression, anxiety, and
minimize substance abuse. An economic evaluation of
school-based programs to prevent depression in adolescents
aged 11 to 17 years demonstrated that both were cost-effective
in an Australian context [48]. However, this was a modeled
evaluation limited to the prevention of depression, based on a
number of assumptions and used disability-adjusted life years
as an outcome measure. A total of 4 cost-benefit analyses
evaluated school-based programs to prevent substance use. The
benefits of the prevention programs and the monetary benefits
of reducing substance use over a lifetime outweighed the costs
to deliver the programs in schools [49-51]. However, these were
also model-based evaluations and conducted in the United States
education and health systems. An economic evaluation
conducted alongside an RCT of these interventions has not been
undertaken nor has an economic evaluation of a combined
Web-based approach to prevent mental and substance use
disorders.
Aim
The study will conduct a long-term (7-year) follow-up of the
first RCT of a combined Web-based substance use and mental
health prevention approach addressing the following research
questions:
1. RQ1: Is the combined approach used in the CSC program
more effective in the long-term across the transition into
early adulthood (ages 18-21 years) compared with: (1)
universal substance use prevention (Climate Substance
Use), (2) universal mental health prevention (Climate
Mental Health), and (3) education as usual (control
condition) for:
• reducing the use and harmful use of alcohol and
cannabis
• reducing overall symptom levels of anxiety and
depression
2. RQ2: How cost-effective is a combined approach to
prevention over the long-term?
We hypothesize that the combined prevention model (CSC
program) will be cost-effective compared with (1) school-based
prevention as usual, (2) stand-alone universal school-based
substance use prevention, and (3) stand-alone anxiety and
depression prevention, where Aus $50,000 per quality-adjusted
life year is taken as the benchmark for cost-effectiveness in
Australia.
Methods
Ethics Approval and Consent to Participate
The study was approved by the University of New South Wales
Human Research Ethics Committee, Australia (HC13073), and
all participants provided informed consent to participate in the
original CSC study. All participants will provide additional
informed consent before participating in further follow-up
surveys.
Study Design
This trial is registered with the Australian and New Zealand
Clinical Trials Registry: 12613000723785. A total of 88 schools
from the Australian states of New South Wales, Western
Australia, and Queensland were recruited to the CSC trial in
2014. A total of 17 schools withdrew after randomization
(primarily due to time constraints). The final cohort at baseline
consisted of 6411 year 8 students from 71 schools (mean age
13.5 years [SD 0.6], 54.78% (3511/6411) female, 81.25%
[5209/6411] born in Australia). Participating schools were
randomized to 1 of 4 conditions: (1) Control (health education
as usual), (2) Climate Substance Use (universal substance use
prevention), (3) Climate Mental Health (universal mental health
prevention), or (4) CSC (universal substance use and mental
health prevention). Blocked randomization was used, allocating
schools to the 4 conditions in equal ratios in blocks of 4. The
CONSORT diagram (see Multimedia Appendix 1) summarizes
participant flow and retention rates through the study for each
condition. Comprehensive information about the intervention
content, delivery, and study design of the original CSC study
has been published in the original CSC study protocol [33]. The
completed CSC study assessments and timeline for extended
follow-up assessments can be seen in Multimedia Appendix 2.
Procedure
The CSC long-term follow-up study will extend data collection
up to 7 years post baseline. Using multiple sources of locator
information already provided to the research team (eg, email
addresses, address, phone number, and Facebook usernames),
all participants will be invited to consent to take part in the
long-term follow-up and then complete 3 Web-based
assessments at approximately 5, 6, and 7 years post baseline.
Participants in the state of Queensland complete school 1 year
earlier than participants in New South Wales and Western
Australia. To collect data from Queensland participants in their
first year post school, follow-up will commence in Queensland
from August 2018 to January 2019, whereas data collection will
run from January 2019 to June 2019 in New South Wales and
Western Australia. Participants will consent to take part in the
longitudinal follow-up study and provide additional consent to
release their Medicare Benefits Schedule and Pharmaceutical
Benefits Scheme information to the research team. Subsequent
contact with students will be made via email invitation or via
school with reminder emails and texts sent once a week for 3
weeks. Those who cannot be reached via email will be contacted
via alternative forms of locator information, including short
messaging service (SMS) and social media. If no response is
received, participants will be followed up via phone calls, and
paper surveys will be mailed to their home address. Participants
will be contacted via the locator information provided until a
response is received.
“Participants will be directed to the CSC website through a
personalized URL to complete written consent procedures and
complete the survey (approximately 30-45 min in duration) on
the Web. Responses will be deidentified and linked over time
using a unique identification code. Participants will be
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reimbursed Aus $20 in the form of a gift voucher for each survey
occasion they complete. A duty of care procedure has been
developed and approved by the University of New South Wales
Human Research Ethics Committee and will be followed if a
participant self-identifies as at risk of harm during the study.
This includes automatic emails to participants with detailed
information about support services if their response indicates
they are at risk of harm.
Sample Size Calculations
Participants for this study come from 6411 students from 71
schools recruited to the original CSC study. Power calculations
for the original trial were based on methods developed to detect
intervention by time interactions in longitudinal cluster RCTs
[52] and ensured adequate power to detect clinically significant
differences across groups both in the total sample and in each
of the 3 states of Australia where recruitment took place. These
calculations accounted for 10% dropout at the school level and
indicated that 2800 students recruited from 28 schools in each
state (for a total of 8400 students) would achieve 80% power
to detect a between-group mean difference of 0.15 (at the P<.05
level) with 7 measurement occasions. In our original study, we
achieved a total sample size of 6411 students. Although this is
not sufficient to do analyses at the state level, the total sample
size is more than sufficient and far surpasses the 2800 required
to detect the expected differences across the whole sample. As
initiation and frequency of substance use as well as levels of
depression and anxiety increase over the transition to early
adulthood [9], larger effect sizes are expected over the
longer-term follow-up. Thus, even allowing conservatively for
dropout rates of >35%, the proposed follow-up study is
adequately powered for the expected size of effect for Climate
Substance Use (d=0.15), Climate Mental Health (d=0.15), and
the CSC intervention (d=0.2). Power calculations based on the
obtained sample, where there were at least 16 schools, and an
average of at least 80 students per school in each intervention
group show that the power to detect an effect size of d=0.15 at
the final long-term follow-up would be >90%.
Measures
Where possible, measures have remained consistent from the
original CSC study to the long-term follow-up study. Some
measures have been amended or updated to be age appropriate
as participants transition out of school. Details of all included
measures in the long-term follow-up study are outlined below.
Demographic data including gender, age, country of birth,
truancy rates, and academic performance were obtained at
baseline to determine the equivalence of groups. All follow-up
outcomes will be assessed by validated self-report measures,
which have been shown to be valid and reliable in adolescent
populations [53-55].
Primary Measures
Alcohol Use
Drinking behaviors in the past 6 months will be assessed using
an adapted version of the Patterns of Alcohol index [56].
Participants will report the frequency and average quantity of
their alcohol consumption in standard drinks, frequency of binge
drinking (defined as consuming 5 or more standard drinks on
1 occasion), the maximum number of drinks consumed on 1
occasion, and the proportion of their friends or acquaintances
who drink alcohol and drink to get drunk. From this scale, it
will be possible to calculate dichotomous variables to determine
whether participants have ever had a sip, full serve of alcohol,
or binge drunk (consumed 5 or more standard drinks). This
questionnaire has been used in previous Climate Schools trials
[57-59] and allows for comparison with large-scale Australian
cohorts. A standard drinks chart will be presented with these
items to assist reporting. Emerging symptoms of alcohol use
disorder will be screened for by a Diagnostic and Statistical
Manual of Mental Disorders-fifth edition (DSM-5) symptom
checklist [60]. This 16-item checklist examines the presence of
symptoms in the past 12 months as specified in the DSM-5 and
includes items such as, “during the past 12 months, have you
tried unsuccessfully to reduce your use of alcohol?”
Alcohol-related harms will be measured by the 24-item Brief
Young Adult Alcohol Consequences Questionnaire [61]. Items
capture a wide range of age-appropriate harms from mild (eg,
fatigue) to more severe (eg, sexual victimization) consequences
during the past year.
Cannabis Use
Cannabis use will be assessed by 4 items from the National
Drug and Alcohol Strategy Household Survey (NDSHS) [62].
Items will assess whether participants have ever tried cannabis,
their frequency of use in the past 6 months, and proportion of
their friends and acquaintances who use cannabis. Emerging
symptoms of cannabis use disorder will be screened by a 17-item
DSM-5 symptom checklist, which assesses the absence or
presence of symptoms in the past 12 months [60].
Other Substance Use
A total of 6 items from the NDSHS [62], allowing for
comparison with a large representative group of Australians,
will ask participants whether they have ever tried amphetamines,
ecstasy, hallucinogens, sedatives, inhalants, or any other
substance and their frequency of use in the last 6 months (on a
5-point scale ranging from “none” to “more than five times”).
Questions will be presented alongside a table with alternative
names for drugs. Cigarette and electronic cigarette use will be
measured by 7 questions modified from Barrington-Trimis et
al [63]. Questions assess whether participants have ever tried
cigarettes or electronic cigarettes, their frequency of use in the
past 6 months and 30 days, and the average quantity of cigarettes
smoked per day in the past 30 days.
Mental Health Measures
Psychological distress in the past month will be assessed by the
Kessler 6 scale [64] and the Distress Questionnaire-5 [60].
Depressive and anxiety symptoms during the past 2 weeks will
be measured by the Patient Health Questionnaire-9 modified
for adolescents [65] and the 7-item Generalized Anxiety
Disorder scale, respectively [66]. The 3-item Mini Social Phobia
Inventory [67] will screen for social phobia, whereas the
Community Assessment of Psychic Experiences Positive
Scale-15 [68] will measure psychotic-like experiences during
the past 3 months. A total of 3 dichotomous questions drawn
from the Youth Risk Behavior Surveillance System [69] and 1
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question from the Patient Health Questionnaire-9 [65] will assess
suicidal ideation in the past 12 months, including thoughts of
and plans to attempt suicide.
Resource Utilization
Participants’ will be consented for access to Medicare Benefits
Schedule and Pharmaceutical Benefits Scheme data providing
detailed information on the number and cost of contacts with
health care professionals and prescription medications
reimbursed through these commonwealth-funded plans. These
data will be obtained from the Department of Human Services
for up to a 4.5-year period from the date of extraction. A
retrospective 12-month questionnaire will also be used to capture
resource use outside of Medicare Benefits Schedule and
Pharmaceutical Benefits Scheme data, in addition to capturing
some overlapping data for those participants who may not agree
to this data access. The resource use questionnaire was adapted
from the Client Services Receipt Inventory [70] and will assess
the frequency of contact with health care professionals, other
service utilization (eg, ambulance, self-help materials), overnight
medical admissions, use of prescription medications, time off
paid and unpaid work, support payments, and living
arrangements.
Health-Related Quality of Life
Health outcomes will be assessed by the Child Heath Utility-9D
[71], a pediatric health-related quality of life measure providing
utility values for economic evaluations, which has been adapted
for Australians aged 18 to 29 years [72].
Secondary Measures
Social Networks
All participants completing Web versions of the survey will
also complete a social networks survey at each time point
consisting of questions adapted from O'Malley et al [73] and
Lau-Barraco et al [74]. Participants will be asked to nominate
up to 6 people with whom they spent most of their free time
with in the past 12 months. For each identified person,
participants will be asked to report on this person’s
demographics, relationships, frequency and mode of contact,
perceived mental health symptoms, perceived alcohol
consumption, whether they are considered a drinking associate,
and relationship closeness. The relationships and closeness
between pairs of nominated individuals will also be rated.
Although these questions were not included in the original phase
of the study, a subsample of participants were asked to nominate
their 6 closest friends in their year at school to provide
information on their social networks in the original CSC study.
Other Measures
Other secondary measures that will be administered include the
following: (1) Bandura’s Resistive Self-Regulatory Efficacy
Scale [75,76] will examine perceived self-efficacy to resist peer
pressure to engage in high-risk activities; (2) the 8-item Frost
Multidimensional Perfectionism Scale-Brief to measure
perfectionism across 2 dimensions (striving and evaluative
concerns) [77]; (3) the 11-item Emotion Regulation
Questionnaire to assess individual differences in the use of 2
emotional regulation strategies (reappraisal and suppression)
[78]; and (4) the Strengths and Difficulties Questionnaire 18+
to assess both internalizing and externalizing symptoms of
participants [79].
Statistical Analysis
Intention-to-treat analyses will be carried out for all primary
and secondary outcomes in the trial, including all participants
in the groups they were initially randomized to. Multilevel
mixed-effects regression models will be used to assess these
outcomes. Where appropriate, generalized mixed-effects models
will be applied, for example, using logistic regression for
dichotomous outcomes.
Multilevel models are able to account for the clustered design
of the trial by taking into account the expected correlations
between the multiple observations of each participant and
between participants in the same school [80]. Multilevel models
will include random intercepts for schools and random intercepts
and slopes for time for individuals. The best fitting random
effects structure for each model will be determined using
likelihood ratio tests and model fit statistics such as the Akaike
information criterion.
Models will include dummy-coded intervention terms that
compare each intervention with the reference control group and
time terms reflecting the survey occasion, along with covariates
such as gender to adjust for possible confounding. The effects
of greatest interest for assessing the effectiveness of the
interventions are intervention × time terms that provide
baseline-adjusted estimates of how each intervention group has
changed relative to control. Interpretable measures of effect size
such as odds ratios and standardized mean differences will be
calculated for all effects as well their accompanying CIs.
Given that some outcome data are expected to be missing due
to loss to follow-up, the analysis must also account for missing
data. As mixed-effects models employ maximum likelihood
estimation, they produce unbiased estimates when missing data
can be assumed to be either missing completely at random or
missing at random [81] and are considered to be superior to
other strategies for dealing with missing data [82].
Planned Comparisons
The primary aims of the original CSC trial were to assess the
efficacy of the combined CSC intervention in comparison with
the stand-alone Climate Substance Use intervention, Climate
Mental Health intervention, and standard education received
by the control group [83]. Therefore, planned comparisons for
each outcome will compare CSC versus Control, CSC versus
Climate Mental Health, and CSC versus Climate Substance Use
including all participants allocated to each of these intervention
groups.
Economic Evaluation
The cost to deliver each intervention will be combined with the
additional resources used by participants over the follow-up
period to calculate total costs from the Australian health sector
and societal perspectives as recommended by current guidelines
[84]. Intervention costs will comprise software development,
staff, and teacher time to deliver interventions and usual care.
Additional health care resources will be valued by applying
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standard Australian unit costs (ie, Independent Hospital Pricing
Authority, Australian Bureau of Statistics wage rates) to the
resource use units collected. The combined CSC intervention
group will be compared with the stand-alone intervention groups
and the control group in terms of both total costs and outcomes
as assessed by an incremental cost-effectiveness ratio.
Nonparametric bootstrapping will be used to obtain CIs for
cost-effectiveness ratios, as parametric techniques are
inappropriate for use on skewed variables and ratios. The
sensitivity of the results will be tested against the variation in
the utility weights and unit cost prices.
Additional Analyses: Moderation of Intervention Effects
To explore possible mechanisms for the interventions’
effectiveness, planned moderation analyses will be conducted
to examine whether measures of baseline risk moderate the
intervention effects. Baseline measures of risk will be
investigated in relation to alcohol and other substance use, harms
related to substance use, and mental health symptoms.
Results
The CSC long-term follow-up study is funded from 2018 to
2022 by the Australian National Health and Medical Research
Council (APP1143555). The first follow-up wave commences
in August 2018, and the results are expected to be submitted
for publication in 2022.
Discussion
Overall Aim
This paper outlines the study protocol and design of an extended
long-term follow-up of the CSC study cohort into late
adolescence and early adulthood. The study aims to (1) examine
the long-term effectiveness of a combined universal mental
health and substance use program (CSC program) in preventing
substance use (and related harms) and reducing mental health
symptoms up to 7 years post baseline and (2) evaluate the
cost-effectiveness of the program over the long term. In addition,
we will explore intervention effects on secondary outcomes
including self-efficacy, social networks, peer substance use,
emotion regulation, and perfectionism into young adulthood as
well as key mediators and moderators of intervention effects.
Strengths and Limitations
This study will address a significant gap in knowledge by
determining for the first time the longevity of school-based
universal prevention for substance use and mental health
delivered via the Web into young adulthood as well as
conducting 1 of the first cost-effectiveness studies of Web-based
prevention for mental health and substance use up to 7 years
post baseline. Furthermore, this will be the first study to examine
unique effects of combining substance use and mental health
prevention over the long term. As with the original CSC study,
2 key limitations of the study are participant attrition and
reliance on self-report for the majority of measures. Although
follow-up rates for the original CSC study remained relatively
high across survey waves (ranging from 66% to 88%), it is
anticipated that the addition of a new round of consent and
participants transitioning from school to postschool
environments in this study will present additional challenges
and increase study attrition. Anticipated barriers include
incomplete and changing contact details, participant relocation
(overseas or interstate for travel, study, or work opportunities),
and a lack of follow-up support from teachers as participants
complete school. To aid in participant follow-up, a set of detailed
follow-up strategies will be developed, including a procedure
using a wide range of mediums to contact participants (email,
SMS, Facebook, phone calls, and mail out), obtaining contact
details from one other person who is likely to know how to
contact the participant should their contact details change, and
adequately reimbursing participants for their time (Aus $20
reimbursement). Reliance on self-report data for the majority
of collected measures may introduce bias related to social
desirability, particularly in relation to illegal or risky behaviors
such as drug use. Nonetheless, self-reported substance use has
been shown to be both reliable and valid [53,54], especially
when confidentiality is assured and when young people self
administer surveys on the Web [55,85], both of which will occur
in this study.
Conclusions
Harms relating to early substance use and development of mental
health problems are a serious concern, and the transition into
early adulthood represents a key risk period. Despite this, very
little is currently known about the effectiveness of school-based
prevention programs beyond school age. This study addresses
a critical knowledge gap and will indicate if prevention
approaches for anxiety, depression, and substance use can have
lasting effects. Furthermore, this study will provide a critical
economic evaluation of the long-term effects of a combined
universal approach to prevent substance use and mental health
problems among young people. This knowledge is vital to
inform policy both nationally and internationally as economic
modeling suggests substantial societal benefit can be gained
from even modest reductions in substance use and mental health
[48,50,86]. Evidence of sustained benefits into adulthood would
provide a scalable and easy-to-implement prevention strategy
that could be disseminated immediately, at minimal cost, to
reduce the considerable harms, burden of disease, injury, and
social costs associated with substance use and mental disorders.
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